NIAID Banner Logo Image

HBV Citations List: July 2024

Literature Citations

1. Preclinical Characterization of a Novel Potent Core Protein Assembly Modulator for the Treatment of Chronic Hepatitis B Viral Infection. Dunkoksung, W., U. Udomnilobol, T. Ruengsatra, N. Chauypen and T. Prueksaritanont. European Journal of Pharmaceutical Sciences, 2024. 200. 106834.
[WOS]. HBV_07_2024

2. Anti-HBV Activities of Cembranoids from the South China Sea Soft Coral Sinularia pedunculata and Their Structure Activity Relationship. Huang, C., Y. Jin, R. N. Sun, K. Y. Hu, L. G. Yao, Y. W. Guo, Z. H. Yuan and X. W. Li. Chemistry and Biodiversity, 2024.e202401146.
[WOS]. HBV_07_2024

3. Discovery of Hepatitis B Virus Subviral Particle Biogenesis Inhibitors from a Bioactive Compound Library. Shrestha, B., S. S. Yang, L. Griffith, J. Ma, F. X. Wang, H. Liu, Q. Zhao, Y. M. Du, J. M. Zhang, J. H. Chang and J. T. Guo. Antiviral Research, 2024. 228. 105955.
[WOS]. HBV_07_2024

Patent Citations

This month, no relevant HBV patents were identified.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2024